BPC-157 and TB-500 are the two most cited peptides in soft-tissue and tendon repair research. They are frequently studied side-by-side, often in stacked protocols, because their mechanisms are complementary rather than overlapping. This article summarises the key differences and the rationale for combining them.
Quick comparison
| Property | BPC-157 | TB-500 |
|---|---|---|
| Full name | Body Protection Compound 157 | Thymosin Beta-4 fragment (TB4 fragment) |
| Length | 15 amino acids | 17 amino acid synthetic fragment (full TB4 is 43 aa) |
| Primary research mechanism | Pentadecapeptide derived from gastric protein; promotes angiogenesis, nitric-oxide pathway modulation | Actin sequestering, increases endothelial cell migration and differentiation |
| Plasma half-life | Short (minutes) | Several hours; longer tissue distribution |
| Typical research dosing cadence | Daily or twice daily | Loading phase 2x/week then maintenance |
Mechanism of action
BPC-157
BPC-157 is a stable synthetic pentadecapeptide derived from a protective protein found in gastric juice. Published animal research has documented effects on tendon-to-bone healing, gastrointestinal ulcer protection and angiogenic vascular response. The proposed mechanisms include upregulation of VEGFR2, modulation of the nitric oxide system and increased fibroblast migration.
TB-500
TB-500 is a synthetic fragment of thymosin beta-4, a naturally occurring 43-amino-acid actin-sequestering peptide. Its activity is centred on the cytoskeleton: it binds G-actin and helps regulate actin polymerization, which is key for cell migration during tissue repair. Animal models show TB-500 promotes endothelial cell migration, accelerates dermal wound closure and protects cardiac tissue under ischemic stress.
Why researchers stack them
The two peptides are usually stacked because they address different parts of the same repair cascade. BPC-157 contributes to angiogenesis and growth-factor signalling. TB-500 contributes to cell migration and actin reorganisation. Together they create a more complete in vitro or animal model of accelerated soft-tissue repair.
A common research protocol uses BPC-157 daily during the active repair phase, with TB-500 administered in a higher loading dose twice per week for the first 4 weeks, followed by a maintenance dose. The exact cadence varies by study design.
Storage and handling
- Lyophilized peptide: store at -20°C long term, 2-8°C for short term.
- Reconstituted in bacteriostatic water: stable at 2-8°C for approximately 28 days.
- Avoid repeated freeze-thaw cycles; aliquot if running time-course experiments.
- Full handling details in our peptide reconstitution guide.
Need a BPC-157 + TB-500 research stack?
AscendLabz supplies third-party-COA verified BPC-157, TB-500 and a pre-formulated BPC/TB stack at the lowest USA price.
Browse Healing Peptides